Geron Jumps: Is Stem Cell Investing Back?

Reader Comments

Back to blog

Geron's approval and with the future Bush veto to be overturned, I see tremendous upside gain for not only the company, but also for mankind. One embryo less than 10 days old can supply all of the stem cells needed for approximately 10,000 spinal cord patients.

Human embryonic stell cells is only a small portion of the patents owned by Geron. They have a new drug going through the FDA approval process called GRN 163 that will eradicate most cancers.

A new drug called TAT2 is being investigated to cure HIV cases.

This approval by the FDA will revolutionize medicine. It will replace the pill and the scapel.

Berry Laws of MO 5:31AM January 25, 2009

I have also invested in this company. This company will be one of the forerunners of stem cell technology.

john of MO 12:09AM January 25, 2009

I have invested in a company called ADVANCED CELL TECHNOLOGY INC "ACTC" I have done much research on this and believe that Dr. Lanza will lead Stem Cells to the top! Take the time to read "A New Theory of the Universe"

http://www.globalmindshift.com/discover/Memebase/The%20American%20Scholar%20-%20A%20New%20Theory%20of%20the%20Universe%20-%20By%20Robert%20Lanza.pdf

Taimie of NV 8:14PM January 24, 2009

Add Your Thoughts
Your comment will be posted immediately, unless it is spam or contains profanity. For more information, please see our Comments FAQ.

Back to blog

The Ticker

The Ticker

Kirk Shinkle is a senior editor at U.S. News. He writes daily about ups and downs in equity markets, sectors and stocks. Formerly, he covered business and economics on both coasts for Investor's Business Daily.

advertisement

advertisement